Skip to main content
Signal8

Landis John B.

SEC insider (Form 3/4/5 filer). CIK 0001477283. Director at EyePoint, Inc. (EYPT). 3 reported Form 4/5 transactions since Sep 2024; latest on Jan 2, 2026. Located in WATERTOWN, MA.

Companies Landis John B. has filed insider reports for

  • EyePoint, Inc. (EYPT): Director
Landis John B. profile photo

Landis John B.

CIK: 0001477283

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)1 (33.3%)

Derivative conversions

Awards (A)2 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

EyePoint, Inc. logo
EYPT

EyePoint, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • EyePoint, Inc. logo
    EYPT

    EyePoint, Inc.

    Jan 2, 2026
    Award

    Stock Option (Right to Buy)

    Direct
    40K shares-
  • EyePoint Pharmaceuticals, Inc. logo
    EYPT

    EyePoint Pharmaceuticals, Inc.

    Jan 5, 2025
    Exercise
    Direct
    10K shares-
  • EyePoint Pharmaceuticals, Inc. logo
    EYPT

    EyePoint Pharmaceuticals, Inc.

    Jan 3, 2025
    Award

    Stock Option (Right to Buy)

    Direct
    40K shares-

1-3 of 3